From low-density lipoprotein to platelet activation

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 11, 2008, Pages 2374-2378

  Akkerman, Jan Willem N ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

ApoE receptor2; CD36; Low density lipoprotein (LDL); p38MAPK; Platelet; Scavenger receptor A

Indexed keywords

LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38;

ATHEROGENESIS; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL AGGREGATION; CELL SECRETION; ENDOCYTOSIS; HUMAN; MACROPHAGE; MORTALITY; NONHUMAN; OXIDATION; SHORT SURVEY; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION;

BLOOD PLATELETS; HUMANS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLATELET ACTIVATION; SIGNAL TRANSDUCTION;

EID: 48349103688     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.04.002     Document Type: Short Survey

References (23)

1. Borén J., Olin K., Lee I., Chait A., Wight T.N., and Innerarity T.L. Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding. J Clin Invest 101 (1998) 2658-2664
2. Collot-Teixeira S., Delorenzo F., and McGregor J.L. Scavenger receptor A and CD36 are implicated in mediating platelet activation induced by oxidized low-density lipoproteins. Arterioscler Thromb Vasc Biol 27 (2007) 2491-2492
3. Essler M., Retzer M., Bauer M., Zangl K.J., Tigyi G., and Siess W. Stimulation of platelets and endothelial cells by mildly oxidized LDL proceeds through activation of lysophosphatidic acid receptors and the Rho/Rho-kinase pathway. Inhibition by lovastatin. Ann NY Acad Sci 905 (2000) 282-286
4. Hackeng C.M., Relou I., Pladet M.W., van Rijn H.J.M., and Akkerman J.W.N. Early platelet activation by low density lipoprotein via p38 mapkinase. Thrombos Haemost 82 (1999) 1749-1756
5. 3. J Biol Chem 274 (1999) 384-388
6. 3-mediated signalling. Arterioscler Thromb Vasc Biol 19 (1999) 239-247
7. Hackeng C.M., Franke B., Relou I.A.M., Gorter G., Bos J.L., van Rijn H.J.M., et al. Low density lipoprotein activates the small GTPases Rap1 and Ral in human platelets. Biochem J 349 (2000) 231-238
8. MAPK. J Biol Chem 279 (2004) 52526-52534
9. Korporaal S.J.A., Gorter G., van Rijn H.J.M., and Akkerman J.W.N. Effect of oxidation on the platelet-activating properties of low density lipoprotein. Arterioscler Thromb Vasc Biol 25 (2005) 1-7
10. Korporaal S.J.A., and Akkerman J.W.N. Platelet signaling induced by lipoproteins. Cardiovasc Hematol Medic Chem 4 (2006) 93-109
11. Korporaal S.J.A., and Akkerman J.W.N. Platelet activation by low density lipoprotein and high density lipoprotein. Pathophysiol Haemost Thromb 35 (2006) 270-280
12. Korporaal S.J.A., van Eck M., Adelmeijer J., Out R., Bezemer M., Lisman T., et al. Platelet activation by oxidized low-density lipoprotein is mediated by CD36-Scavenger Receptor A complex. Arterioscler Thromb Vasc Biol 27 (2007) 2476-2483
13. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
14. 2+ influx in human platelets. J Biol Chem 275 (2000) 19159-19166
15. Pennings M.T., Derksen R.H., Urbanus R.T., Tekelenburg W.L., Hemrika W., and de Groot P.G. Platelets express three different splice variants of ApoER2 that are all involved in signaling. J Thromb Haemost 5 (2007) 1538-1544
16. Podrez E.A., Byzova T.V., Febbraio M., Salomon R.G., Ma Y., Valiyaveettil M., et al. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med 13 (2007) 1086-1095
17. Relou I.A.M., Gorter G., van Rijn H.J.M., and Akkerman J.W.N. Platelet activation by the apoB/E receptor-binding domain of LDL. Thrombos Haemost 87 (2002) 880-887
18. Relou I.A.M., Gorter G., van Rijn H.J.M., and Akkerman J.W.N. Platelet endothelial cell adhesion molecule-1 (PECAM-1) inhibits low density lipoprotein-induced signaling in platelets. J Biol Chem 278 (2003) 32638-32644
19. Relou I.A.M., Bax L.A.B., van Rijn H.J.M., and Akkerman J.W.N. Site-specific phosphorylation of platelet focal adhesion kinase by LDL. Biochem J 369 (2003) 407-416
20. Relou I.A.M., Hackeng C.M., Akkerman J.W.N., and Malle E. Low density lipoprotein and its effect on human blood platelets. Cell Mol Life Sci 60 (2003) 1-11
21. Riddell D.R., Vinogradov D.V., Stannard A.K., Chadwick N., and Owen J.S. Identification and characterization of LRP8 (apoER2) in human blood platelets. J Lipid Res 40 (1999) 1925-1930
22. Shen G.Q., Li L., Girelli D., Seidelmann S.B., Rao S., Fan C., et al. An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction. Am J Hum Genet 81 (2007) 780-791
23. Valiyaveettil M., Kar N., Ashraf M.Z., Byzova T.V., Febbraio M., and Podrez E.A. Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI. Blood 111 (2008) 1962-1971